跳至主要内容
临床试验/NL-OMON55329
NL-OMON55329招募中不适用

My spine is on fire: neuroinflammation in spinal radiculopathy and physiotherapy on it. - NOTICE (NeurOinflammaTion In Cervical radiculopathy)

Vrije Universiteit0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
18 至 99(—)

入选标准

  • Cervical radiculopathy patients
  • Age between 30-65 years.
  • Minimal score of 4 on the Numeric Pain Rating Scale (0-10).
  • Cervical radiculopathy based on the clinical diagnosis confirmed by the
  • Magnetic Resonance Imaging (MRI through a medical specialist). The compression
  • must be caused by a discus protrusion or herniation.
  • Written informed consent of the patient.
  • Referral by a medical specialist
  • High and mixed affinity binders for second generation TSPO radiotracers
  • Evident [11C]-DPA713 binding in the neuroforamina and/or spinal cord. Only
  • applicable for research question 2 and 3.
  • Healthy control
  • Age between 30-65 years.
  • Asymptomatic for neck or shoulder pain and other musculoskeletal conditions
  • in the past 3 months.
  • Written informed consent of the healthy control.
  • Referral by a medical specialist
  • High and mixed affinity binders for second generation TSPO radiotracers

排除标准

  • Cervical radiculopathy patients and healthy control
  • A potential participant who meets any of the following criteria will be
  • excluded from participation in this study:
  • Pregnancy or postpartum for 9 months
  • Contra-indications for venipuncture (e.g. phlebitis)
  • Underwent treatment for current complaints for the last 2 weeks (e.g.
  • physiotherapy, manual therapy, general practitioner etc.)
  • Taken one of the following medications for the last 6 weeks: corticosteroids
  • (e.g. prednisone), immunomodulatory medication (e.g. methotrexate, infliximab
  • etc.) and the use of botox for the last 3 months.
  • Taken one of the following medication: NSAID*s (e.g. diclofenac, ibuprofen,
  • naproxen etc.), Aspirin, Simvastatin (29) for the last week.
  • Benzodiazepine (30) use for the last six weeks.
  • MRI contraindications, (e.g. claustrophobia, inability to lie still in the
  • scanner or metal objects in or around the body)
  • Inability to undergo PET-CT with administration of radioligand [¹¹C]-R-DP713.
  • Significant radiation exposure such that inclusion in this study will take
  • the total dose >10mSv within the preceding 12 months.
  • Current participation in another clinical trial.
  • Previous participation in a PET-CT study in the last 12 months.
  • Having a medical disease with immune system involvement (e.g. MS, Spondylitis
  • Ankylpoetica)

研究者

相似试验